Split History
ETFs Holding AKER »    AKER Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Akers Biosciences is a provider of diagnostic solutions. Co. focuses primarily on the commercialization of its Particle Immuno-Filtration Assay (PIFA®) technology platform. Co.'s marketed/pipeline product includes: BreathScan™, which is a disposable breath alcohol detector; PIFA® Heparin/PF4 and PIFA PLUSS® PF4, which are tests for Heparin/PF4 antibodies to detect an allergy to the blood thinner, Heparin; Rapid Blood Cell Separation, marketed under the brand name seraSTAT®, which accelerates the rate at which a test result is obtained; and Tri-Cholesterol Check®, which is a test for total and high density lipoprotein cholesterol and estimates low density lipo protein. According to our AKER split history records, Akers Biosciences has had 2 splits.
AKER split history picture
Akers Biosciences (AKER) has 2 splits in our AKER split history database. The first split for AKER took place on November 08, 2018. This was a 1 for 8 reverse split, meaning for each 8 shares of AKER owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split. AKER's second split took place on November 25, 2019. This was a 1 for 24 reverse split, meaning for each 24 shares of AKER owned pre-split, the shareholder now owned 1 share. For example, a 125 share position pre-split, became a 5.20833333333333 share position following the split.

When a company such as Akers Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the AKER split history from start to finish, an original position size of 1000 shares would have turned into 5.20833333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Akers Biosciences shares, starting with a $10,000 purchase of AKER, presented on a split-history-adjusted basis factoring in the complete AKER split history. AKER split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/23/2014
End date: 12/10/2019
Start price/share: $1,057.92
End price/share: $2.97
Dividends collected/share: $0.00
Total return: -99.72%
Average Annual Total Return: -63.17%
Starting investment: $10,000.00
Ending investment: $28.07
Years: 5.88
Date Ratio
11/08/20181 for 8
11/25/20191 for 24
AKER is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ALBO Split History
ALC Split History
ALIM Split History
ALKS Split History
ALPN Split History
ALQA Split History
ALR Split History
ALT Split History
ALXA Split History
ALXN Split History

Also explore: AKER shares outstanding history

QuickLogic Corporation (QUIK)
iMedia Brands, Inc. (IMBI)
Akers Biosciences, Inc. (AKER)
NeuroMetrix, Inc. (NURO)
TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AKER Insider Buying

AKER Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.